Surgical implications of vascular endothelial physiology

Surgery

Volumn 122, Issue 3, 1997, Pages 516-526

  Cain, Brian S ^a   Meldrum, Daniel R ^a   Selzman, Craig H ^a   Cleveland Jr , Joseph C ^a   Meng, Xianzhong ^a   Sheridan, Brett C ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FREE RADICAL; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; THROMBOXANE A2;

BLOOD VESSEL TONE; CELL INTERACTION; CELL METABOLISM; CLINICAL TRIAL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LEUKOCYTE ADHERENCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0030885429     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90123-9     Document Type: Review

References (140)

1. Bruke E. An essay on the cause of the coagulation of the blood. British Foreign Med Chir Review 1857;19:183-212.
2. Verrier ED, Boyle EM. Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg 1996;62:915-22.
3. Davies MG, Tripathi SC. Mechanical stress mechanisms and the cell: an endothelial paradigm. Circ Res 1993;72:239-45.
4. Davies MG, Hagen PO. The vascular endothelium: a new horizon. Ann Surg 1993;218:593-609.
5. Eisenberg PR. Endothelial cell mediators of thrombosis and fibrinolysis: review in depth. Coron Artery Dis 1991;2:129.
6. Gertler JP, Abbott WM. Prothrombotic and fibrinolytic functions of the normal and perturbed endothelium. J Surg Res 1992;52:89-95.
7. Davies MG, Hagen PO. Pathobiology of intimai hyperplasia. BrJ Surg 1994;81:1254-69.
8. O'Leary JP. The physiologic basis of surgery. In: Blackbourne LH, Cope JT, Tribble RW, Tribble CG, editors. The cardiovascular system. 2nd ed. Baltimore: Williams and Wilkins; 1996. p 349.
9. Moncada S, Gryglewski RJ, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxidases to an unstable substance that inhibits platelet agreggation. Nature 1976;263:663-5.
10. Tateson JE, Moncada S, Vane JR. Effects of prostacyclin (PGX) on cylic AMP concentrations in human platelets. Prostaglandins 1977;13:389-97.
11. Piper P, Vane JR. The release of prostaglandins from lung and other tissues. Ann N Y Acad Sci 1971;180:363-85.
12. Davies MG, Hagen PO. Physiology of the arterial system, including the effects of nitric oxide. In: Sabiston DC, Lyerly HK, editors. Textbook of surgery: the biologic basis of modern surgical practice. 15th ed. Philadelphia: WB Saunders Company; 1997. p 1620-6.
13. Vane JR, Anggard EE, Botting RM. Regulatory functions of vascular endothelium. N Engl J Med 1990;323:27-36.
14. Furchgott RF, ZawadzkiJV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetyl choline. Nature 1980;288:373-6.
15. Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerine, and nitric oxide in various tissue prepartations and comparison to the effects of sodium azide and hydroxlamine. J Cyclic Nucleotide Res 1977;3:23-35.
16. Kahn MT, Furchgott RF. Similarities of behavior of nitric oxide (NO) and endothelium-derived relaxing factor in a perfusion cascade bioassay system. Fed Proc 1987;46:385.
17. Ignarro LJ, Burns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor (EDRF) released from artery and vein appears to be nitric oxide (NO) or a closely related species. Fed Proc 1987;46:644.
18. Hecker M, Mitchell JA, Vane JR. The generation of L-arginine in endothelial cells is linked to the release of endothelium-derived relaxing factor. Eur J Pharmacol 1990;176:253-4.
19. Sessa WC. The nitric oxide synthase family of proteins. J Vase Res 1994;31:131-43.
20. Vane JR. The Croonian Lecture, 1993. The endothelium: maestro of the circulation. Philos Trans R Soc London 1994;434:225-46.
21. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Nad Acad Sci (U S A) 1989;86:3375-8.
22. Vallance P, Collier J, Moncada S. Effects of endothelium derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2:997-1000.
23. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dialator mechanism appears abnormal. J Hypertens 1992;10:1025-31.
24. Forstermann U, Pollock J, Schmidt H, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Nad Acad Sci (U S A) 1991;88:1788-92.
25. Gross SS, Jaffe EA, Levi R, Kilbourn RG. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterine-dependent, calmodulin-independent, and inhibited by arginine analogues with a rank-order of potency characteristic of activated macrophages. Biochem Biopyhs Res Commun 1991;178:823-9.
26. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:639-46.
27. Garg UC, Hassid A. Nitric oxide-generating vasodiators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat smooth muscle cells. J Clin Invest 1989;83:1174-7.
28. Gryglewski RJ, Botting RM, Vane JR. Mediators produced by the endothelial cell. Hypertension 1988;12:530-48.
29. Selke FW, Boyle EM, Verrier ED. Endothelial cell injury in cardiovascular surgery: the pathophysiology of vasomotor dysfunction. Ann Thorac Surg 1996;62:1222-8.
30. Luscher T. Endothelium-derived relaxing factors and regulation of vascular tone in human blood vessels. Lung 1990;suppl:27-34.
31. Fullerton DA, Agarafojo J, McIntyre RCC. Pulmonary vascular smooth muscle relaxation by cAMP-mediated mechanisms. J Surg Res 1996;61:444-8.
32. Fullerton DA, Hahn AR, Banerjee A, Harken AH. Pulmonary vascular smooth muscle relaxation by cGMP-versus cAMP-mediated mechanisms. J Surg Res 1994;57:259-63.
33. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci (U S A) 1975;72:2994-8.
34. Yanagisawa M, Kurihara H, Kimura S. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
35. Ohlstein EH, Storer BL, Butcher JA, Debouck C, Feuerstein G. Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells. Circ Res 1991;69:832-41.
36. Simonson MS, Wann S, Mene P, Dubyak GR, Kester M, Dunn MJ. Endothelin-1 activates the phosphoinositide cascade in cultured glomerular mesangial cells. J Cardiovasc Pharmacol 1989;13(suppl 5):S80-3.
37. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest 1989;83:1162-7.
38. Power RF, Warton J, Zhao Y, Bloom SR, Polak JM. Autoradiographic localization of endothelin-1 binding sites in the cardiovascular and respiratory systems. J Cardiovasc Pharmacol 1989;13(suppl 5):S50-6.
39. Badr KF, Murray JJ, Breyer MD, Takahashi K, Ingami T, Harris RC. Mesangial cell, golmerular, and renal vascular responses to endothelin in the rat kidney: elucidation of signal transduction pathways. J Clin Invest 1989;83:336-42.
40. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet activating factor research. Pharmacol Rev 1987;39:97-145.
41. Bensard DD, Banerjee A, McIntyre RC, Berens RL, Harken AH. Endotoxin disrupts beta-adrenergic signal transduction in the heart. Arch Surg 1994;129:198-205.
42. Anderson BO, Bensard DD, Harken AH. The role of platelet activating factor and its antagonists in shock, sepsis, and multiple organ failure. Surg Gynecol Obstet 1991;172:415-24.
43. Briner VA, Luscher TF. Role of vascular endothelial abnormalities in clinical medicine: atherosclerosis, hypertension, diabetes, and endotoxemia. Adv Intern Med 1994;39:1-22.
44. Camussi G, Agiletta M, Malavassi F. The release of platelet activating factor from human endothelial cells in culture. J Immunol 1983;131:2397-403.
45. Suttorp N, Seeger W, Uhl J. Pseudomonas aeruginosa cytotoxin stimulates prostacyclin production in cultured endothelial cells. J Cell Physiol 1985;123:64-72.
46. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859-73.
47. McEver RP. Structure, function, and regulation of molecules involved in leukocyte adhesion. In: Lipsky PE, Rothlein R, Kishimoto TK, Fannes RB, Smith CW, editors. Leukocyte interactions mediated by P-selectin. New York: Springer-Verlag; 1993. p 135-50.
48. Geng JG, Bevilaqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-120. Nature 1990;343:757-60.
49. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989;84:92-9.
50. Eppihimer MJ, Wolitzky B, Anderson DC, Labrow MA, Granger DN. Heterogeneity of expression of E- and P-selectins in vivo. Circ Res 1996;79:560-9.
51. Cartwright GE, Athens JW, Wintrobe MM. Kinetics of granulopoiesis in normal man. Blood 1964;24:780.
52. Adams DH, Shaw S. Leukocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994;343:831-6.
53. Springer TA. Traffic signals on edothelium for lymphocyte recirculation and leukocyte emigration. Ann Rev Physiol 1995;57:827-72.
54. Fries RS, Rehring TF, Wollmering M, Moore EE, Ketch LL, Banerjee A, et al. Trauma primes cells. Shock 1994;1:1-7.
55. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-6.
56. Marlin SD, Springer TA. Purified intracellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associcated antigen 1 (LFA-1). Cell 1987;51:813-9.
57. Anderson BO, Bensard DD, Brown JM, Repine JE, Shanley DF, Leff JA, et al. FMLP injures endotoxin primed rat lung by neutrophil dependent and independent mechanisms. AmJ Physiol 1991:R413-20.
58. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and Interferon gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54.
59. Arnout MA. The structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990;75:1037-50.
60. Diamond MS, Springer TA. The dynamic regulation of integrin adhesiveness. Curr Biol 1994;4:506-17.
61. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150, 95 glycoproteins. Ann Rev Med 1987;38:175-94.
62. Johnston GI, Cook RG, McEver RP. Cloning of GMP-140, a granule membrane of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989;56:1033-44.
63. Frenette PS, Wagner DD. Adhesion molecules-Part I: blood vessels and blood cells. N Engl J Med 1996;334:1526-9.
64. McEver RP. Role of selectins in leukocyte adhesion to platelets and endothelium. Ann N Y Acad Sci 1994;714:185-9.
65. Kishimoto TK, Jutila MA, Berg EL, Butcher EC. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989;245:1238-41.
66. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 1996;84:563-74.
67. Hahne M, Jager U, Isenmann S, Hallmann R, Vestweber D. Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J Cell Biol 1993;121:655-64.
68. Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of human vascular endothelial cells. J Immunol 1986;136:1680-7.
69. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-Kappa B and cytokine-inducible enhancers. FASEB J 1995;9:899-909.
70. Etzioni A, Frydman M, Pollack S. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 1992;327:1789-92.
71. Bosse R, Vestweber D. Only simultaneous blocking of the L-and P- selectin completely inhibits neutrophil migration into mouse peritoneum. Eur J Immunol 1994;24:3019-24.
72. Grosso MA, Brown JM, Muluin D, Velasco SE, Repine JE, Harken AH. Xanthine oxidase derived oxygen radicals induce pulmonary edema via direct endothelial cell injury. J Surg Res 1989;46:355-60.
73. Meldrum DR, Cleveland JC, Sheridan BC, Rowland RT, Banerjee A, Harken AH. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Thorac Surg 1996;61:1273-80.
74. Cleveland JC, Wollmering MM, Meldrum DR, Rowland RT, Rehring TF, Sheridan BC, et al. Ischemic preconditioning in human and rat ventricle. Am J Physiol 1996;271:H1786-94.
75. Banerjee A, Winter-Locke C, Rogers K, Mitchell M, Brew E, Carins C, et al. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha-1 adrenergic mechanism. Circ Res 1993;65:1201-11.
76. Ogawa S, Gerlach H, Esposito C, Pasagian-Macaulay A, Brett J, Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. J Clin Invest 1990;85:1090-8.
77. Ogawa S, Koga S, Kuwabara K, Morris S, Belezikian J, Silverstein S, et al. Hypoxia-induced increased vascular permeability and lowering of cellular cAMP levels. Am J Physiol 1992;262:C546-54.
78. Armoule T, Michiels C, Remacle J. Increased PMN adher-ence on ECs after hypoxia: involvement of PAF, 18/CD11B, and ICAM-1. Am J Physiol 1993;264:C1102-10.
79. Brown JM, Buealer GJ, Berger EM, Grosso MA, Whitman GJ, Terada LS, et al. Albumin decreases hydrogen peroxide and reperfusion injury in isolated rat heart. Inflammation 1989;13:583-9.
80. Bensard DD, Brown JM, Anderson BO, Shanley PF, Grosso MA, Harken AH. Induction of endogenous anti-oxidant enzyme activity attenuates myocardial reperfusion injury. J Surg Res 1990;49:126-31.
81. Boyle EM, Pohlman TH, Cornejo CJ, Verrier ED. Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion. Ann Thorac Surg 1996;62:1868-75.
82. Virkhaus R, Lucchesi BR, Simpson PJ, Shebuski RJ. The role of adhesion molecules in cardiovascular pharmacology: meeting review. J Pharmacol Exp Ther 1995;273:569-75.
83. Bevilaqua MP, Pober JS, Majeau GR. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of IL-1. Proc Natl Acad Sci (U S A) 1986;83:4533-7.
84. Bevilaqua MP, Schleef RR, Gimbrone MA, Loskutoff DJ. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 1986;78:587-91.
85. Nemerson Y. The tissue factor pathway of coagulation. Semin Hematol 1992;29:170-6.
86. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-51.
87. Verrier ED. The vascular endothelium: friend or foe? Ann Thorac Surg 1993;55:818-9.
88. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary induced multisystem organ failure. Ann Thorac Surg 1993;56:S92-6.
89. Libby P, Ordovas JM, Auger KR, Robbins AH, Birinyi LK, Dinarello CA. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. AmJ Pathol 1986;124:179-85.
90. Warner SJC, Auger KR, Libby P. Interleukin-1 induces production of interleukin-1 by adult human vascular endothelial cells in vitro. J Immunol 1987;139:1911-7.
91. Abbas AK, Lichtman AH, Pober JS, editors. Cellular and molecular immunology. Philadelphia: WB Saunders; 1991. p 225-43.
92. Libby P, Warner SJ, Friedman GB. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 1988;81:487-93.
93. Miyauchi T, Yanagisawa M, Tomizawa T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989;2:53-4.
94. Douglas SA, Ohlstein EH. Endothelin-1 promotes neo-intima formation after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1993;22(suppl 8):S371-3.
95. Tomita K, Ujiie K, Nakanishi T. Plasma endothelin levels in patients with acute renal failure. N Engl J Med 1989;321:1127.
96. Ross RD, Kalidini V, Vincent JA. Acute changes in endothelin-1 after hemodialysis for chronic renal failure. J Pediatr 1993;122:S74-6.
97. McMillen MA, Sumpio BE. Endothelins: polyfunctional cytokines. J Am Coll Surg 1995;180:621-37.
98. Masaki T. Possible role of endothelin in endothelial regulation of vascular tone. Ann Rev Pharmacol Toxicol 1995;35:235-55.
99. Pinsky DJ. The vascular biology of heart and lung presertion for transplantation. Thromb Haemost 1995;74:58-65.
100. Frenette PS, Wagner DD. Adhesion molecules-Part II: blood vessels and blood cells. N Engl J Med 1996;335:43-5.
101. Fullerton DA, Eisenach JH, Friese RS, Agrafojo J, Sheridan BC, McIntyre RC. Impairment of endothelial-dependent pulmonary vasorelaxation after mesenteric ischemia/reperfusion. Surgery 1996;120:879-84.
102. Fullerton DA, Eisenach JH, McIntyre RC, Friese RS, Sheridan BC, AgrafojoJ, et al. Inhaled nitric oxide prevents pulmonary endothelial dysfunction after mesenteric ischemia-reperfusion. Am J Physiol 1996;271 (part 1):L326-31.
103. Pinsky DJ, Oz MC, Koga S, Taha Z, Broekman MJ, Marcus AJ, et al. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest 1994;93:2291-7.
104. Worral NK, Lazenby WD, Misko TP, Lin TS, Rodi CP, Manning PT, et al. Modulation of in-vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995;181:63-70.
105. Yang X, Chowdhury N, Cai B, Brett J, Marboe C, Sciacca RR, et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994;94:714-21.
106. Fullerton DA, McIntyre RC, Mitchell MB, Campbell DN, Grover FL. Lung transplantation with cardiopulmonary bypass exaggerates pulmonary vasomotor dysfunction in the transplanted lung. J Thorac Cardiovasc Surg 1995;109:212-6.
107. Salvemini D, Korbut R, Aggard E, Vane J. Immediate release of a nitric-oxide like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci (U S A) 1990;87:2593-7.
108. Kaplan AP, Reddigari S, Brunee T, Nishikawa K, Kuna P, Silverberg M. Studies on the activation and inhibition of the plasma kallikrein-kinin system. Agents Actions 1992;38(suppl 3):413-20.
109. Cumming AD, Nimmo JR, Craig KJ, Gilchrist A, Hayes PC. Vasoactive effects of aprotinin. Agents Actions 1992;38(suppl 2):211-8.
110. Szabo C, Mitchell JA, Gross SS, Thiemermann C, Vane JR. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993;108:786-92.
111. Forstermann U, Closs EJ, PollockJS, Nkane M, Schwartz P. Nitric oxide synthase isoforms: characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121-31.
112. Michael T, Li GK, Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci (U S A) 1993;90:6252-6.
113. Palmer RMJ, Bridge L, Foxwell NA. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 1992;105:11-2.
114. Pfeilshifter J. Platelet derived growth factor inhibits cytokine induction of nitric oxide synthase in rat glomerular mesangial cells. Eur J Pharmacol 1991;208:339-40.
115. Hooper TL, Thomson DS, Jones MT. Amelioration of lung ischemic injury with prostacyclin. Transplantation 1990;49:1031-5.
116. Jurmann HJ, Dammenhayn L, Schafers HJ, Wahlers T, Fieguth HG, Haverich A. Prostacyclin as an additive to single crystalloid flush: improved pulmonary preservation in heart-lung transplantation. Transplant Proc 1987;19:4103-4.
117. Kirk AJB, Colquhoun IW, Dark JH. Lung preservation: a view of current practice and future directions. Ann Thorac Surg 1993;56:990-1000.
118. Strom TB, Carpenter CB. Prostaglandin as an effective antirejection therapy in rat renal allograft recipients. Transplantation 1983;35:279-80.
119. Moncada S, Flower RJ, Vane JR. Prostaglandins, prostacyclins, thrombooxane A2, and leukotrienes. In: Gilman AG, Goodman LS, Rail TW, Murad F, editors. The pharmacologic basis of therapeutics. New York: MacMillan; 1985. p 660-73.
120. Jones G, Hurley JV. The effect of prostacyclin in the adhesion of leucocytes to injured vascular endothelium. J Pathol 1984;142:51-9.
121. Fantone JC, Marasco WA, Elgas LJ, Ward PA. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. Am J Pathol 1984;115:9-16.
122. Fantone JC, Funkel SL, Ward PA, Zurier RB. Supression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators. J Immunol 1980;125:2591-6.
123. Conte JV, Foegh ML. Lung preservation: a new indication for a PAF antagonist, BN 52021. In: O'FlahertyJP, Ran PW, editors. PAF antagonists: new developments for application. Woodlands (TX): Portfolio publications; 1990. p 129-37.
124. Corcoran PC, Wang Y, Katz NM. Platelet activating factor antagonist enhances lung preservation in a model of single lung allotransplantation. J Thorac Cardiovasc Surg 1992;104:66-72.
125. Naka Y, Chowdhury NC, Liao H, Michler RE, Stern DM, Pinsky DJ. Elevation of intracellular cAMP by a phosphodiesterase inhibitor or cAMP analogues improves vascular function in orthotopic rat lung transplants. Circulation 1994;90(suppl):I-804.
126. Pinsky DJ, Oz MC, Liao H, Morris S, Brett J, Morales A, et al. Restoration of the cyclic AMP second messenger pathway enhances cardiac preservation for cardiac transplantation in a heterotopic rat model. J Clin Invest 1993;92:2994-3002.
127. Pinsky DJ, Naka Y, Chowdhury NC, Liao H, Oz MC, Michler RE, et al. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci (U S A) 1994;91:12086-90.
128. Yamashita M, Schmid RA, Ando K, Cooper JD, Patterson GA. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg 1996;62:791-7.
129. Harlan JM, Winn RK, Vedder NB, Doerschuk CM, Rice CL. Adhesion: its role in inflammatory disease. In: Harlan JM, u D, editors. In vivo models of leukocyte adherence to endothelium. New York: Freeman; 1992. p 117-50.
130. Coller BS, Anderson K, Weisman HF. New anti-platelet agents: platelet GPIIb/IIIa antagonists. Thromb Haemostasis 1995;74:302-8.
131. Gold HK, Garabedian HD, Dinsmore RE, Guerrero LJ, Cigarroa JE, Palacios IF, et al. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators: observations in animals and humans. Circulation 1997;95:1755-9.
132. Winn RK, Vedder NB, Michelcic D, Flaherty LC. The role of adhesion molecules in reperfusion injury. Agents Actions 1993;41:113-26.
133. Cosimi AB, Conti D, Delmonico FL, Preffer FI, Wee SL, Rothlein R, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 1990;144:4604-12.
134. Haug CE, Colvin RB, Delmonico FL, Auchincloss HJ, Rubin-Tolkoff N, Preffer FI, et al. A phase I trial of immunosupression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993;55:766-72.
135. Adams DH, Hubscher SG, Shaw J, Rothlein R, Neuberger JM. Intracellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989;2:1122-5.
136. Lang T, Krams SM, Villanueva JC, Cox K, So S, Martinez OM. Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection. Transplantation 1995;59:584-9.
137. Weyrich AS, Ma X, Leefer DJ, Albertine KH, Leefer AM. In vivo neutralization of P-Selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-9.
138. Bienvenu K, Granger DN. Molecular determinants of shear rate-dependent leukocyte adhesion in post-capillary venules. Am J Physiol 1993;264:H1504-8.
139. Friedman G, Jankowski S, Shahla M, Goldman M, Rose RM, Kahn RJ, et al. Administration of an antibody to E-selectin in patients with septic shock. Grit Care Med 1996;24:229-33.
140. Mulligan MS, Paulson JC, DeFrees S, Zheng ZL, Lowe JB, Ward PA. Protective effects of oligosaccarides in P-selectin-dependent lung injury. Nature 1993;364:149-51.